Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | divalent metal transporter DMT1B | 0.0065 | 0.3008 | 0.2423 |
Trypanosoma brucei | protein kinase, putative | 0.0116 | 0.6895 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0116 | 0.6895 | 1 |
Brugia malayi | MAP kinase sur-1 | 0.0116 | 0.6895 | 0.6635 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0116 | 0.6895 | 0.5 |
Schistosoma mansoni | divalent metal transporter DMT1B | 0.0065 | 0.3008 | 0.2951 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0116 | 0.6895 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0116 | 0.6895 | 0.6635 |
Schistosoma mansoni | alpha-glucosidase | 0.0135 | 0.8349 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0116 | 0.6895 | 0.6635 |
Plasmodium falciparum | transporter, putative | 0.0065 | 0.3008 | 0.5 |
Schistosoma mansoni | alpha-glucosidase | 0.0135 | 0.8349 | 1 |
Schistosoma mansoni | divalent metal transporter DMT1B | 0.0065 | 0.3008 | 0.2951 |
Plasmodium vivax | metal transporter, putative | 0.0065 | 0.3008 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0116 | 0.6895 | 0.8081 |
Brugia malayi | NRAMP-like transporter K11G12.4 | 0.0065 | 0.3008 | 0.2423 |
Echinococcus granulosus | divalent metal transporter DMT1B | 0.0065 | 0.3008 | 0.2423 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0116 | 0.6895 | 0.6635 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0035 | 0.0773 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0116 | 0.6895 | 1 |
Mycobacterium ulcerans | manganese transport protein MntH | 0.0065 | 0.3008 | 1 |
Mycobacterium leprae | DIVALENT CATION-TRANSPORT INTEGRAL MEMBRANE PROTEIN MNTH (BRAMP) (MRAMP) | 0.004 | 0.115 | 1 |
Mycobacterium tuberculosis | Divalent cation-transport integral membrane protein MntH (BRAMP) (MRAMP) | 0.004 | 0.115 | 0.5 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0157 | 1 | 1 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0116 | 0.6895 | 1 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0157 | 1 | 1 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0116 | 0.6895 | 1 |
Toxoplasma gondii | divalent metal transporter, putative | 0.0065 | 0.3008 | 0.3652 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0116 | 0.6895 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0116 | 0.6895 | 0.6635 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0157 | 1 | 1 |
Onchocerca volvulus | 0.0091 | 0.5 | 1 | |
Trichomonas vaginalis | CMGC family protein kinase | 0.0116 | 0.6895 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0116 | 0.6895 | 0.6635 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.3008 | 0.2423 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0116 | 0.6895 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0116 | 0.6895 | 1 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0116 | 0.6895 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0116 | 0.6895 | 1 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0035 | 0.0773 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.3008 | 0.2423 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0157 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0116 | 0.6895 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 10 uM | Inhibition of NRAMP1 expressed in CHO cells | ChEMBL. | 22749870 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.